Filing Details

Accession Number:
0001127602-14-001333
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-01-06 18:27:09
Reporting Period:
2013-12-20
Filing Date:
2014-01-06
Accepted Time:
2014-01-06 18:27:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
850693 Allergan Inc AGN Pharmaceutical Preparations (2834) 951622442
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1298941 M Scott Whitcup 2525 Dupont Drive
Irvine CA 92612
Executive Vp, R&D, Cso No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-12-20 16,500 $0.00 33,827 No 4 M Direct
Common Stock Disposition 2013-12-20 16,500 $107.80 17,327 No 4 S Direct
Common Stock Acquisiton 2013-12-20 16,500 $0.00 33,827 No 4 M Direct
Common Stock Disposition 2013-12-20 16,500 $109.80 17,327 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2013-12-20 16,500 $0.00 16,500 $36.15
Common Stock Employee Stock Option (Right to Buy) Disposition 2013-12-20 16,500 $0.00 16,500 $36.15
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
40,700 2015-02-08 No 4 M Direct
24,200 2015-02-08 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,707 Indirect By 401(k)
Common Stock 1,739 Indirect By Esop
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 30, 2012.
  2. Shares allocated to reporting person's SIP account as of reporting date.
  3. Shares allocated to the reporting person's ESOP account as of reporting date.
  4. The option becomes exercisable in four equal annual installments beginning February 9, 2006.